inhibited by the presence of patient 1gM. The addition of increasing concentrations of patient 1gM resulted in gradually decreased thrombin generation rates. In contrast to this, even a high concentration of normal 1gM had no inhibitory effect on the rate of prothrombin activation (Fig. 2B ). In the absence of phospholipids ( Fig. 2A) Xa-mediated activation of prothrombin. Therefore, the effect of patient 1gM on prothrombin activation by factor Xa (2 sg/ml) in the presence of factor V (1-2 U/ml), was investigated.
In an initial experiment, we observed a 4-5-fold decrease in thrombin generation rates by the addition of patient 1gM (0.5 mg/ml), whereas normal 1gM had no such effect. This result was difficult to explain, since the results of coagulation assays ( figure) .
In the experiments illustrated in Fig. 3 , the 1gM was added at the same time as factor Xa. If, instead, the 1gM was added 5-10 mm after the reactions had been started by factor Xa, all further prothrombin activation was effectively inhibited (not shown in figure) . 
